Equity and dividends
As per 4th October 2016, the company reported equity is NOK 52 709 799 consisting of 17 569 933 shares with a nominal value of NOK 3,- per share.
The Board of Directors continuously assesses the working capital and investment capital needed to meet future growth, especially within the field of pharma, and has considered this to be more important than paying dividends. However, a policy of not paying dividends has not been adopted by the Board.
No dividends have been paid to the Company’s shareholders for the period 2004 - 2016.